Cargando…

Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis

Non-small-cell lung cancer (NSCLC) causes significant mortality worldwide. Patients with chronic renal failure have an increased risk of developing lung cancer. NSCLC Patients with chronic renal failure undergoing hemodialysis (HD) often exhibit poor performance, and chemotherapy is generally contra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Chou-Chin, Hsieh, Po-Chun, Huang, Chun-Yao, Yang, Mei-Chen, Su, Wen-Lin, Wu, Chih-Wei, Wu, Yao-Kuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294878/ https://www.ncbi.nlm.nih.gov/pubmed/35979322 http://dx.doi.org/10.12998/wjcc.v10.i19.6360

Ejemplares similares

Tyrosine kinase inhibitors and human epidermal growth factor receptor-2 positive breast cancer
por: Abunada, Aya, et al.
Publicado: (2023)

Comparison of T790M Acquisition After Treatment With First- and Second-Generation Tyrosine-Kinase Inhibitors: A Systematic Review and Network Meta-Analysis
por: Hsieh, Po-Chun, et al.
Publicado: (2022)

Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function
por: Lee, Chang-Hee, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery
por: Huang, Chun‐Yao, et al.
Publicado: (2022)

Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors
por: Lemos, C, et al.
Publicado: (2008)

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
por: Stuckey, Ruth, et al.
Publicado: (2020)

Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004)

Current understanding of the role of tyrosine kinase 2 signaling in immune responses
por: Muromoto, Ryuta, et al.
Publicado: (2022)

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease
por: Wu, Chih-Wei, et al.
Publicado: (2019)

Bacteremia in hemodialysis patients
por: Suzuki, Masashi, et al.
Publicado: (2016)

Targeting the epidermal growth factor receptor
por: El-Rayes, B F, et al.
Publicado: (2004)

Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease
por: Lan, Chou-Chin, et al.
Publicado: (2023)

Early pulmonary rehabilitation of COVID-19 patients in an isolation ward and intensive care unit
por: Lan, Chou-Chin, et al.
Publicado: (2022)

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
por: Blackledge, G, et al.
Publicado: (2004)

Epidermal growth factor signalling and bone metastasis
por: Lu, X, et al.
Publicado: (2010)

Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors
por: Chang, Bee-Song, et al.
Publicado: (2022)

Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors
por: Hsu, Ping-Chih, et al.
Publicado: (2023)

Different Responses to Pulmonary Rehabilitation in COPD Patients with Different Work Efficiencies
por: Jao, Lun-Yu, et al.
Publicado: (2022)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Vitamin D and calcium signaling in epidermal stem cells and their regeneration
por: Oda, Yuko, et al.
Publicado: (2020)

The roles of sodium-potassium-chloride cotransporter isoform-1 in acute lung injury
por: Hsieh, Po-Chun, et al.
Publicado: (2021)

Poor Work Efficiency is Associated with Poor Exercise Capacity and Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
por: Yang, Shih-Hsing, et al.
Publicado: (2021)

Treating with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Accompanying Lower Incidence of Second Primary Cancers
por: Chou, Wen-Ru, et al.
Publicado: (2022)

Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Comparison of the effects of the three major tyrosine kinase inhibitors as first-line therapy for non-small-cell lung cancer harboring epidermal growth factor receptor mutations
por: Tu, Chih-Yen, et al.
Publicado: (2018)

The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan
por: Wu, Chih-Wei, et al.
Publicado: (2021)

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors
por: Holderfield, M, et al.
Publicado: (2014)

Disruption of Cytosolic Folate Integrity Aggravates Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Modulates Metastatic Properties in Non-Small-Cell Lung Cancer Cells
por: Shen, Po-Wen, et al.
Publicado: (2021)

Human epidermal growth factor receptor 2 targeted therapy in endometrial cancer: Clinical and pathological perspectives
por: Saito, Ayumi, et al.
Publicado: (2021)

Tale of two kinases: Protein kinase A and Ca(2+)/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy
por: Gaitán-González, Pamela, et al.
Publicado: (2021)

Therapeutic effects and mechanisms of actions of Descurainia sophia
por: Hsieh, Po-Chun, et al.
Publicado: (2020)

Nucleoside diphosphate kinase A as a controller of AMP-kinase in airway epithelia
por: Muimo, Richmond, et al.
Publicado: (2006)

Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
por: Wang, Dan, et al.
Publicado: (2023)

Deep Learning-based Artificial Intelligence Improves Accuracy of Error-prone Lung Nodules
por: Lan, Chou-Chin, et al.
Publicado: (2022)

Cancer treatment with kinase inhibitors: what have we learnt from imatinib?
por: Ross, D M, et al.
Publicado: (2004)

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2015)

Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitors
por: Chen, Yu-Mu, et al.
Publicado: (2016)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
por: Valenzuela, Guillermo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2kujlp0sladg0pm8si3ds16ku